A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment of Paroxysmal Atrial Fibrillation (PAF)
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 354 participants.
Also called NCT06455098
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 354 participants
- Sponsor
- Registry
-
NCT06455098
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Australia
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT06455098. Allocation not applicable; no masking; primary purpose treatment. Start 2024-06-28 (actual); primary completion 2027-07-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment of Paroxysmal Atrial Fibrillation (PAF)
- Acronym
- OMNY-AF
- Condition
- Atrial Fibrillation
- Intervention (Device)
- OMNYPULSE™ Catheter with the TRUPULSE Generator
- Lead sponsor
- Biosense Webster, Inc.
Record details
- Record id
cardio:ct-nct06455098- Content hash
1a6749bcf3d2c452b72cb071442bf38d09b3d9c24e71516a26dfeb770c09ac67